Follow-up
We evaluated the treatment response, survival outcomes, and toxicity using medical records. Follow-up data available as of April 2020 were included in the analysis. Hematological and nonhematological toxicity after IREC therapy were graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0.